{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:14:39Z","timestamp":1780589679449,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204706"],"award-info":[{"award-number":["82204706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2022MD723714"],"award-info":[{"award-number":["2022MD723714"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Provincial Science and Technology Department","award":["2021YFH0150"],"award-info":[{"award-number":["2021YFH0150"]}]},{"DOI":"10.13039\/501100019868","name":"Sichuan Provincial Key Laboratory of Shock and Vibration of Engineering Materials and Structures, Southwest University of Science and Technology","doi-asserted-by":"publisher","award":["2022YFS0635"],"award-info":[{"award-number":["2022YFS0635"]}],"id":[{"id":"10.13039\/501100019868","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Foundation of TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province","award":["SZKF202212"],"award-info":[{"award-number":["SZKF202212"]}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021LZXNYD-Z09"],"award-info":[{"award-number":["2021LZXNYD-Z09"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>NLRP3 inflammasome immoderate activation results in the occurrence of various inflammatory diseases, but the clinic medications targeting NLRP3 inflammasome are still not available currently. The strategy of drug repurposing can reorient the direction of therapy, which is an indispensable method of drug research. In this study, an antimicrobial agent chlorquinaldol (CQ) was conducted to assess the effect on NLRP3 inflammasome and novel clinical value on NLRP3-driven diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The effect of CQ on NLRP3 inflammasome activation and pyroptosis was studied in mouse and human macrophages. ASC oligomerization, intracellular potassium, reactive oxygen species production, and NLRP3-ASC interaction were used to evaluate the suppression mechanism of CQ on inflammasome activation. Finally, the ameliorative effects of CQ in the model of LPS-induced peritonitis, dextran sodium sulfate (DSS)-induced colitis, and monosodium urate (MSU)-induced gouty arthritis were evaluated in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CQ is a highly powerful NLRP3 inhibitor that has feeble impact on the NLRC4 or AIM2 inflammasome activation in mouse and human macrophages. Further study indicated that CQ exhibits its suppression effect on NLRP3 inflammasome by blocking NLRP3-ASC interaction and hydroxyl on the benzene ring is vital for the assembly and activation of NLRP3 inflammasome. Furthermore, in vivo experiments demonstrated that administration of CQ has outstanding therapeutic action on LPS-induced peritonitis, DSS-induced colitis, and MSU-induced gouty inflammation in mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Collectively, the current study discoveries the antimicrobial agent CQ as a potentially specific NLRP3 inhibitor, and its use provides a feasible therapeutic approach for the treatment of NLRP3-driven diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-024-01016-1","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T10:43:37Z","timestamp":1734605017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extinguishing the flames of inflammation: retardant effect of chlorquinaldol on NLRP3-driven diseases"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5518-954X","authenticated-orcid":false,"given":"Zhilei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"1","key":"1016_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","volume":"74","author":"T Asselah","year":"2021","unstructured":"Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168\u201384.","journal-title":"J Hepatol"},{"issue":"9","key":"1016_CR2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59(9):1192\u20139.","journal-title":"Gut"},{"key":"1016_CR3","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2147\/IDR.S211007","volume":"12","author":"A Bidossi","year":"2019","unstructured":"Bidossi A, Bottagisio M, De Grandi R, Drago L, De Vecchi E. Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance. Infect Drug Resist. 2019;12:2177\u201389.","journal-title":"Infect Drug Resist"},{"key":"1016_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fmicb.2017.01039","volume":"8","author":"M Bortolin","year":"2017","unstructured":"Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L. In vitro antimicrobial activity of chlorquinaldol against microorganisms responsible for skin and soft tissue infections: comparative evaluation with gentamicin and fusidic acid. Front Microbiol. 2017;8:1039.","journal-title":"Front Microbiol"},{"key":"1016_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110122","volume":"365","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen X, Liang S, Ou Y, Lin G, Hua L, et al. Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Chem Biol Interact. 2022a;365: 110122.","journal-title":"Chem Biol Interact"},{"issue":"11","key":"1016_CR6","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1016\/j.cclet.2022.03.110","volume":"33","author":"Z Chen","year":"2022","unstructured":"Chen Z, Jiaxin L, Meng X, Di W, Yan Q, Liang Z, et al. Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy. Chin Chem Lett. 2022b;33(11):4924\u20139.","journal-title":"Chin Chem Lett"},{"issue":"1","key":"1016_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","volume":"20","author":"J Chen","year":"2023","unstructured":"Chen J, Jin Z, Zhang S, Zhang X, Li P, Yang H, et al. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cell Mol Immunol. 2023;20(1):51\u201364.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1016_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-020-01590-2","volume":"39","author":"G Ciliberto","year":"2020","unstructured":"Ciliberto G, Mancini R, Paggi MG. Drug repurposing against COVID-19: focus on anticancer agents. J Exp Clin Cancer Res. 2020;39(1):86.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1016_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/bib\/bbaa288","volume":"22","author":"S Dotolo","year":"2021","unstructured":"Dotolo S, Marabotti A, Facchiano A, Tagliaferri R. A review on drug repurposing applicable to COVID-19. Brief Bioinform. 2021;22(2):726\u201341.","journal-title":"Brief Bioinform"},{"issue":"1","key":"1016_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1):35\u201352.","journal-title":"Immunol Rev"},{"key":"1016_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11658-020-00236-7","volume":"25","author":"Y Fang","year":"2020","unstructured":"Fang Y, Zhang Z. Arsenic trioxide as a novel anti-glioma drug: a review. Cell Mol Biol Lett. 2020;25:44.","journal-title":"Cell Mol Biol Lett"},{"key":"1016_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-med-081117-041238","volume":"70","author":"I Gantois","year":"2019","unstructured":"Gantois I, Popic J, Khoutorsky A, Sonenberg N. Metformin for treatment of fragile X syndrome and other neurological disorders. Annu Rev Med. 2019;70:167\u201381.","journal-title":"Annu Rev Med"},{"issue":"7590","key":"1016_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354\u20137.","journal-title":"Nature"},{"issue":"1","key":"1016_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250\u20136.","journal-title":"J Med Virol"},{"issue":"9","key":"1016_CR15","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1016_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni AS, Gubbi S, Barzilai N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 2020;32(1):15\u201330.","journal-title":"Cell Metab"},{"issue":"1","key":"1016_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","volume":"8","author":"MA Kutny","year":"2022","unstructured":"Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, et al. Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children\u2019s Oncology Group AAML1331 Trial. JAMA Oncol. 2022;8(1):79\u201387.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1016_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153499","volume":"23","author":"Q Li","year":"2022","unstructured":"Li Q, Feng H, Wang H, Wang Y, Mou W, Xu G, et al. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction. EMBO Rep. 2022;23(2): e53499.","journal-title":"EMBO Rep"},{"issue":"1","key":"1016_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53(1):19\u201325.","journal-title":"Immunity"},{"issue":"5","key":"1016_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41590-022-01192-4","volume":"23","author":"J Moretti","year":"2022","unstructured":"Moretti J, Jia B, Hutchins Z, Roy S, Yip H, Wu J, et al. Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome. Nat Immunol. 2022;23(5):705\u201317.","journal-title":"Nat Immunol"},{"issue":"5","key":"1016_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18(5):1141\u201360.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"1016_CR22","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","volume":"24","author":"V Parvathaneni","year":"2019","unstructured":"Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today. 2019;24(10):2076\u201385.","journal-title":"Drug Discov Today"},{"issue":"3","key":"1016_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova I, Korbonits M. Metformin\u2013mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10(3):143\u201356.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1016_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41\u201358.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"1016_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","volume":"20","author":"VAK Rathinam","year":"2019","unstructured":"Rathinam VAK, Zhao Y, Shao F. Innate immunity to intracellular LPS. Nat Immunol. 2019;20(5):527\u201333.","journal-title":"Nat Immunol"},{"issue":"15","key":"1016_CR26","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133(15):1630\u201343.","journal-title":"Blood"},{"issue":"5","key":"1016_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139.","journal-title":"Nat Immunol"},{"issue":"7575","key":"1016_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135.","journal-title":"Nature"},{"issue":"1","key":"1016_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/med.21844","volume":"42","author":"M S\u00f6nksen","year":"2022","unstructured":"S\u00f6nksen M, Kerl K, Bunzen H. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors. Med Res Rev. 2022;42(1):374\u201398.","journal-title":"Med Res Rev"},{"issue":"7381","key":"1016_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278\u201386.","journal-title":"Nature"},{"key":"1016_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022;236: 108053.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1016_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneph.2015.175","volume":"12","author":"J Wada","year":"2016","unstructured":"Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12(1):13\u201326.","journal-title":"Nat Rev Nephrol"},{"key":"1016_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100889","volume":"76","author":"L Wang","year":"2020","unstructured":"Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med. 2020;76: 100889.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"1016_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2019.02.003","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin b. 2019a;9(4):734\u201344.","journal-title":"Acta Pharm Sin b"},{"issue":"12","key":"1016_CR35","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00204-019-02606-3","volume":"93","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xu G, Zhan X, Liu Y, Gao Y, Chen N, et al. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice. Arch Toxicol. 2019b;93(12):3585\u201399.","journal-title":"Arch Toxicol"},{"issue":"1","key":"1016_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-019-1211-2","volume":"38","author":"JC Wang","year":"2019","unstructured":"Wang JC, Li GY, Wang B, Han SX, Sun X, Jiang YN, et al. Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation. J Exp Clin Cancer Res. 2019c;38(1):235.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"1016_CR37","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.apsb.2020.03.006","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xu G, Wang H, Zhan X, Gao Y, Chen N, et al. Icariside II, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation. Acta Pharm Sin b. 2020;10(9):1619\u201333.","journal-title":"Acta Pharm Sin b"},{"issue":"2","key":"1016_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134601","volume":"6","author":"G Xu","year":"2021","unstructured":"Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6(2): e134601.","journal-title":"JCI Insight."},{"issue":"6","key":"1016_CR39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect. 2020;80(6):607\u201313.","journal-title":"J Infect"},{"issue":"2","key":"1016_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.335","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Hu B, Sun YF, Huang XW, Cheng JW, Huang A, et al. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF\/JAK1\/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021;11(2): e335.","journal-title":"Clin Transl Med"},{"key":"1016_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2022.110894","volume":"221","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang X, Xiao M, Ma J, Qu Y, Zou L, et al. Nano-in-micro alginate\/chitosan hydrogel via electrospray technology for orally curcumin delivery to effectively alleviate ulcerative colitis. Mater des. 2022;221: 110894.","journal-title":"Mater des"},{"issue":"7329","key":"1016_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135.","journal-title":"Nature"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-024-01016-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:09:13Z","timestamp":1734606553000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-01016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1186\/s10020-024-01016-1","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiment protocols were approved by the Animal Care Committee of the Chengdu University of Traditional Chinese Medicine (No. 2024024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}